Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar Willodjw (< 20) Submitted: 4/29/2010 4:53:48 AM : Outperform Start Price: $5.48 CYTX Score: -70.21

cytx

Featured Broker Partners


Advertisement